Alphatec Holdings Inc. Common Stock (ATEC)
Stock · NASDAQ · Health Care
$10.46as of 10/16/2026
Price chart
Active signals
ATEC Signal Track Record
How signals performed across all stocks →What ATEC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | +2.1% | 57% | September 9, 2026 |
| Bollinger Band Breakout | 21 | +2.1% | 57% | September 11, 2026 |
| Bollinger Band Breakdown | 20 | -0.6% | 50% | September 9, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -3.5% | 40% | January 27, 2026 |
| Any 20-session window (baseline) | +0.5% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ATEC
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX Syste…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 913
- Website
- atecspine.com/
Fundamentals
- 1-day range
- $10.41$11.14
- Market cap
- $1.42B
- P/E (trailing)
- —
- P/E (forward)
- 17.42
- EPS (trailing)
- $-0.72
- Dividend yield
- —
- Beta
- 0.82
- Avg. volume
- 2.19M
- Dividend pay date
- August 25, 2016
How Alphatec Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
14 analyst ratings
Alphatec Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ATECAlphatec Holdings Inc. Common Stock$10.46▼ 4.30%Market cap $1.42BP/E —$6.82$23.29
- KMTSKestra Medical Technologies Ltd. Common Stock$27.24▼ 5.02%Market cap $1.48BP/E —$17.34$30
- IARTIntegra LifeSciences Holdings Corporation Common Stock$13.21▼ 2.37%Market cap $1.33BP/E —$8.7$20.49
- AORTArtivion Inc. Common Stock$21.78▼ 0.41%Market cap $1.29BP/E 117.64$19.16$48.25
- TNDMTandem Diabetes Care Inc. Common Stock$16.24▼ 1.69%Market cap $1.29BP/E —$12.26$29.65
- BVSBioventus Inc. Class A Common Stock$13.3▼ 3.69%Market cap $1.17BP/E 21.32$6.46$15.89
- IRMDiRadimed Corporation Common Stock$88.27▼ 1.23%Market cap $1.17BP/E 49.82$71.34$107.9
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ATEC Alphatec Holdings Inc. Common Stock | $1.42B | — | $10.46 | ▼ 4.30% | $6.82$23.29 |
| KMTS Kestra Medical Technologies Ltd. Common Stock | $1.48B | — | $27.24 | ▼ 5.02% | $17.34$30 |
| IART Integra LifeSciences Holdings Corporation Common Stock | $1.33B | — | $13.21 | ▼ 2.37% | $8.7$20.49 |
| AORT Artivion Inc. Common Stock | $1.29B | 117.64 | $21.78 | ▼ 0.41% | $19.16$48.25 |
| TNDM Tandem Diabetes Care Inc. Common Stock | $1.29B | — | $16.24 | ▼ 1.69% | $12.26$29.65 |
| BVS Bioventus Inc. Class A Common Stock | $1.17B | 21.32 | $13.3 | ▼ 3.69% | $6.46$15.89 |
| IRMD iRadimed Corporation Common Stock | $1.17B | 49.82 | $88.27 | ▼ 1.23% | $71.34$107.9 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Alphatec CEO Miles Patrick Purchases 115,000 Shares for $1 Million. Is the Medical Tech Stock Now a Buy?Yahoo · 9/30/2026
- ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and StrategyYahoo · 9/23/2026
- Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?Yahoo · 9/14/2026
- Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On FridayBenzinga · 9/11/2026
Insider Activity
Insider Actions →- Carls Thomas Andrew · October 5, 2026 · Grant200.0K
- Miles Patrick · September 10, 2026 · Buy115.0K @ $8.81
- Marshall Tyson Eliot · August 5, 2026 · Sale8.2K @ $9.65
- Karen K. McGinnis · June 11, 2026 · Sale6.0K @ $8.01
- David R. Pelizzon · June 10, 2026 · Grant32.0K
- Quentin S. Blackford · June 10, 2026 · Grant32.0K
- Demski David M · June 10, 2026 · Grant32.0K
- Berkowitz Mortimer III · June 10, 2026 · Grant32.0K
- Valentine Keith · June 10, 2026 · Grant32.0K
- Karen K. McGinnis · June 10, 2026 · Grant32.0K
- Valentine Keith · May 11, 2026 · Buy35.0K @ $7
- Valentine Keith · May 8, 2026 · Buy43.8K @ $7.54
- Valentine Keith · May 7, 2026 · Buy56.2K @ $7.49
Institutional Ownership
March 31, 2026
- Total shares held
- 117.86M
- Total value held
- $1.27B
- Institutional holders
- 278
- Unknown10.09M
- Unknown7.16M
- Unknown6.42M
- Unknown5.62M
- Unknown4.91M
- Unknown3.62M
- Unknown3.03M
- Unknown2.91M
- Unknown2.85M
- Unknown2.81M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Alphatec Appoints Tommy Carls as EVP for Data Intelligence
Alphatec Holdings has named Tommy Carls as Executive Vice President of Data Intelligence and Strategy. This leadership addition focuses on the company's data capabilities and strategic direction. The stock is currently trading within its 52-week range, with analyst targets averaging $15.79.
Alphatec Appoints Tommy Carls as EVP for Data Intelligence. Alphatec Holdings has named Tommy Carls as Executive Vice President of Data Intelligence and Strategy. This leadership addition focuses on the company's data capabilities and strategic direction. The stock is currently trading within its 52-week range, with analyst targets averaging $15.79.